OW 2025 4 - 7 November 2025

STEP UP: efficacy of semaglutide in obesity treatment targets and cardiovascular risk thresholds

Authors :

Carel W le Roux1,2; W. Timothy Garvey3; Kristoffer Jensen Kolnes4; Jøran Hjelmesæth5; Ildiko Lingvay6; Niklas Kahr Rasmussen4; Volker Schnecke4; Luca Busetto7

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Download infographic (.pdf)
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)